Jump Financial’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-89,386
Closed -$2.13M 2035
2026
Q1
$2.13M Buy
+89,386
New +$2.48M 0.03% 628
2025
Q4
Sell
-144,500
Closed -$3.51M 1938
2025
Q3
$3.51M Buy
+144,500
New +$2.87M 0.04% 520
2025
Q1
Sell
-34,498
Closed -$856K 1598
2024
Q4
$856K Sell
34,498
-8,601
-20% -$220K 0.02% 820
2024
Q3
$1.06M Buy
+43,099
New +$1.11M 0.02% 777
2023
Q4
Sell
-32,330
Closed -$778K 1790
2023
Q3
$778K Buy
32,330
+5,105
+19% +$137K 0.03% 796
2023
Q2
$869K Buy
+27,225
New +$884K 0.03% 754
2023
Q1
Sell
-37,463
Closed -$1.47M 1593
2022
Q4
$1.47M Buy
+37,463
New +$1.68M 0.08% 339
2022
Q3
Sell
-61,614
Closed -$2.39M 1597
2022
Q2
$2.39M Buy
61,614
+8,468
+16% +$337K 0.1% 269
2022
Q1
$3.04M Buy
+53,146
New +$3.49M 0.13% 193
2021
Q4
Sell
-19,570
Closed -$1.7M 1382
2021
Q3
$1.7M Buy
+19,570
New +$1.97M 0.12% 185
2021
Q2
Sell
-27,338
Closed -$2.19M 1087
2021
Q1
$2.19M Buy
+27,338
New +$2.6M 0.2% 64

Other funds holding BEAM

Jump Financial's BEAM Position: Q2 2026 in Review

Jump Financial sold out of Beam Therapeutics (BEAM) in Q2 2026, closing a stake of 89,386 shares — an estimated $2.13M sold.

Jump Financial first reported a position in BEAM in Q1 2021 and held it in 11 quarters. The position peaked at $3.51M in Q3 2025. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Jump Financial reported no remaining Beam Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jump Financial sold 89,386 Beam Therapeutics shares in Q2 2026, an estimated $2.13M.
  • Jump Financial first reported a position in Beam Therapeutics in Q1 2021 and held it in 11 quarters.
  • Jump Financial's Beam Therapeutics position peaked at $3.51M in Q3 2025.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.